19 October 2017
News and Views
Links and Services
April's issue of Gastroenterology investigates whether statin use after a diagnosis of esophageal cancer is associated with reduced esophageal cancer–specific and all-cause mortality.
Statins (3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors), commonly prescrib
Email this page to a colleague
GastroHep.com is a Blackwell Publishing registered trademark
© 2017 Wiley-Blackwell and GastroHep.com and contributors